Share on:
Carlyle Group has hired investment bank Natixis to explore a sale of its stake in French medical equipment company Groupe Marle.
Marle specializes in orthopaedic implants, made from both alloys and polyethylene, and sells its products worldwide. The company is reported to produce one million implants annually and recorded €85MM (~US $97MM) in revenue for 2015.
Carlyle Group bought an 80% interest in Marle in 2009. The Marle family and management team retained a 20% stake.
Source: Wall Street Journal Â
In October 2015, Marle announced the acquisition of Finortho SAS, a company that specializes in polishing and sintering for rapid prototyping. Finortho was officially incorporated into Marle in January 2016 and became Marle Finishing SAS.
RELATED ARTICLES
Janco Medical to Focus on Packaging and Cleanroom Manufacturing
Apr 10 2024 , Julie A. Vetalice
Evonik Grows Capacity for Customized RESOMER Powder Biomaterials
Apr 10 2024 , Julie A. Vetalice
Exploring Why Automation Leads to Improved Medical Device Manufacturing
Apr 09 2024 , Lowell